Search
Search Results
##search.searchResults.foundPlural##
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3852PDF: 2665HTML: 1712 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9587PDF: 6344HTML: 88332Fig.1b: 302Fig.1c: 302Fig.2a: 297Fig.2b: 265Fig.4: 320Fig.2c: 283Fig.3: 281Tab.1: 342Tab.2: 314Tab.3: 308Tab.4: 347Fig1a: 297 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3082PDF: 1364HTML: 2853Figure 1: 225 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3673PDF: 1378HTML: 2417Fi.1 Gritti.Rambaldi: 264 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3637PDF: 884HTML: 3039Figure 1a and 1b: 213Figure 2: 224Figure 3: 218Figure 4: 211Figure 5: 207Tables 1-5: 185 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4498PDF: 2057HTML: 5570Table 1: 300 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5999PDF: 1626HTML: 1686Untitled: 287 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2518PDF: 1407HTML: 17239Bassan Fig.1: 188Bassan Fig.2: 292Bassan Fig.4: 175Fig.3: 308 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4808PDF: 3960HTML: 383 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2131PDF: 876HTML: 675 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1822PDF: 1178HTML: 200 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1577PDF: 904HTML: 3154 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2764PDF: 1751HTML: 2466Table1: 291 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1481PDF: 655HTML: 4203 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2499PDF: 2186HTML: 260 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2544PDF: 1090HTML: 1680Fig 1: 271Tab I: 263Cover Letter: 273 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3973PDF: 1720HTML: 892Figures . Eliassian: 328 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1473PDF: 506HTML: 18642Figure 1: 208Figure 2: 191Figure 3: 207Figure 4: 244Figure 5: 213 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1188PDF: 1001Suppl. Files: 632HTML: 114 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1665PDF: 992HTML: 2018Figure: 223Tables: 232ALL revision 1: 346response to reviewer: 234 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3955PDF: 1744HTML: 114 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2729PDF: 1839HTML: 738 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1321PDF: 656HTML: 6943 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2356PDF: 937HTML: 386 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2453PDF: 903HTML: 1708Figure 1: 268Table 1: 260 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1502PDF: 658Suppl. Files: 399HTML: 186 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1473PDF: 588HTML: 311 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1783PDF: 823HTML: 1518 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2507PDF: 816HTML: 2160Untitled: 293Untitled: 201Untitled: 234Untitled: 215Untitled: 232Untitled: 248Untitled: 237







